Page last updated: 2024-10-24

candesartan and Fetal Death

candesartan has been researched along with Fetal Death in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borthen, C1
Oglaend, B1
Eggebøe, T1
Ellingsen, CL1
Schjøtt, J1

Other Studies

1 other study available for candesartan and Fetal Death

ArticleYear
Warnings against candesartan in pregnancy are not implemented in physicians' practice.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 146, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Co

2009